Correlation Between Cyclo Therapeutics and Ubiquitech Software

Can any of the company-specific risk be diversified away by investing in both Cyclo Therapeutics and Ubiquitech Software at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclo Therapeutics and Ubiquitech Software into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cyclo Therapeutics and Ubiquitech Software, you can compare the effects of market volatilities on Cyclo Therapeutics and Ubiquitech Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclo Therapeutics with a short position of Ubiquitech Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclo Therapeutics and Ubiquitech Software.

Diversification Opportunities for Cyclo Therapeutics and Ubiquitech Software

0.28

Correlation Coefficient

Cyclo Therapeutics  Ubiquitech Software

Modest diversification

The 3 months correlation between Cyclo and Ubiquitech is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Cyclo Therapeutics and Ubiquitech Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ubiquitech Software and Cyclo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclo Therapeutics are associated (or correlated) with Ubiquitech Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ubiquitech Software has no effect on the direction of Cyclo Therapeutics i.e., Cyclo Therapeutics and Ubiquitech Software go up and down completely randomly.

Pair Corralation between Cyclo Therapeutics and Ubiquitech Software

Given the investment horizon of 90 days Cyclo Therapeutics is expected to generate 1620.21 times less return on investment than Ubiquitech Software. But when comparing it to its historical volatility, Cyclo Therapeutics is 67.44 times less risky than Ubiquitech Software. It trades about 0.01 of its potential returns per unit of risk. Ubiquitech Software is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Ubiquitech Software on September 12, 2024 and sell it today you would earn a total of  0.01  from holding Ubiquitech Software or generate 9.223372036854776E16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Cyclo Therapeutics  vs.  Ubiquitech Software

Cyclo Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cyclo Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Cyclo Therapeutics is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Ubiquitech Software

Risk-Adjusted Performance

24 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Ubiquitech Software are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Ubiquitech Software unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cyclo Therapeutics and Ubiquitech Software

The main advantage of trading using opposite Cyclo Therapeutics and Ubiquitech Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclo Therapeutics position performs unexpectedly, Ubiquitech Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ubiquitech Software will offset losses from the drop in Ubiquitech Software's long position.

The idea behind Cyclo Therapeutics and Ubiquitech Software pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.